Loading patent…
AssigneeAgouron Pharmaceuticals, Inc.
InventorsBruce A. Dressman, James E. Fritz, Marlys Hammond, William J. Hornback, Stephen W. Kaldor, Vincent J. Kalish, John E. Munroe, Siegfried H. Reich, John H. Tatlock, Timothy A. Shepherd, Michael J. Rodriguez
Estimating the term…
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
A compound of the formula ##STR136## or a prodrug thereof or a pharmaceutically acceptable salt thereof.
A compound of the formula ##STR138##
Dependencies are inferred from the claim text.